Camlin Fine Sciences cash flow

Latest FY26

Cash from operations: ₹82.1cr+207.1% on FY25
Capital spending: ₹57.6cr+35.6% on FY25
Free cash flow: ₹24.5cr−₹15.7 cr in FY25
Cash from financing: −₹24.6cr₹72.4 cr in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	74.0	73.7	78.6	62.5
	—	−103	146	0.0	9.7
	—	82.1	100	60.3	58.5
	—	−3.5	0.0	−1.2	−0.7
	—	−4.4	0.0	−6.6	4.2
	—	2.0	0.0	0.0	2.4
	—	−21.3	25.8	36.6	−8.9
	—	17.7	−251	86.5	1.8
	—	59.3	0.0	0.0	0.0
	—	0.0	0.0	31.2	30.3
	—	−21.0	−71.3	0.0	−206
	—	−2.2	0.0	10.6	0.0
	—	0.0	0.0	0.7	33.6
	—	72.3	−7.1	0.0	3.1
	—	−12.6	0.0	−10.9	0.0
Cash from operating activities
	−67.6	−33.6	49.0	−99.2	80.4
	—	139	15.9	286	−9.3
	—	106	64.9	187	71.1
	—	23.7	38.2	47.5	20.2
	—	82.1	26.7	139	50.9
Cash from investing activities
	—	57.6	42.4	60.6	144
	—	0.0	0.0	0.6	0.9
	—	32.8	0.0	0.0	0.7
	—	0.0	30.5	0.0	0.0
	—	0.0	0.0	0.0	10.1
	—	0.0	0.8	0.0	0.0
	—	3.0	0.9	1.2	0.7
	—	34.5	−4.1	−7.7	28.8
	—	−53.0	−75.3	−66.5	−125
Cash from financing activities
	—	0.0	223	0.0	0.0
	—	0.5	0.2	0.6	0.5
	—	68.9	0.0	25.2	80.8
	—	17.2	70.6	0.0	−52.3
	—	16.4	10.5	10.9	8.2
	—	60.6	69.6	72.8	51.9
	—	0.0	0.0	−28.1	−13.9
	—	−24.6	72.4	−86.0	59.7
	—	4.5	23.8	−13.5	−14.1
	—	4.5	23.8	−13.5	−14.1
	—	—	—	80.3	93.7
Reference items
	85.9	107	208	73.9	205
	4.6%	6.2%	12.5%	4.6%	12.2%
	24.5	24.5	−15.7	78.4	−93.4
	—	−13.6	−97.3	−116	—
	₹1.28	₹1.28	−₹0.82	₹4.08	−₹4.86
	64.54×	—	—	—	—
	—	3.49×	−0.17×	−1.33×	1.28×
	—	23.7	38.2	47.5	20.2
	—	60.6	69.6	72.8	51.9

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

CAMLINFINE₹82.32

Camlin Fine Sciences Limited

· Chemicals

₹ CrorePeersCLEAN DEEPAKNTR BAYERCROP TIRUMALCHM ATUL SHK PAUSHAKLTD ANURASMcap ₹1,581 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	62.5	78.6	73.7	74.0	—
+ Impairment Loss / (Reversal)	9.7	0.0	146.2	-102.9	—
+ Finance Costs	58.5	60.3	100.1	82.1	—
+ Interest Income	-0.7	-1.2	0.0	-3.5	—
+ Fair Value (Gains) / Losses	4.2	-6.6	0.0	-4.4	—
+ Share-based Payments	2.4	0.0	0.0	2.0	—
+ Unrealised FX (Gain) / Loss	-8.9	36.6	25.8	-21.3	—
+ Other Non-cash Items	1.8	86.5	-251.4	17.7	—
+ Other Reconciling Items	0.0	0.0	0.0	59.3	—
Changes in Working Capital
+ Other Financial Assets — Current	30.3	31.2	0.0	0.0	—
+ Other Current Assets	-205.8	0.0	-71.3	-21.0	—
+ Other Non-current Assets	0.0	10.6	0.0	-2.2	—
+ Other Financial Liabilities — Current	33.6	0.7	0.0	0.0	—
+ Other Current Liabilities	3.1	0.0	-7.1	72.3	—
+ Other Non-current Liabilities	0.0	-10.9	0.0	-12.6	—
Cash from Operating Activities
Profit Before Tax (per I/S)	80.4	-99.2	49.0	-33.6	-67.6
+ Total Adjustments (incl. Working Capital)	-9.3	285.8	15.9	139.4	—
Cash from Operations (pre-tax)	71.1	186.5	64.9	105.7	—
+ Income Taxes Paid	20.2	47.5	38.2	23.7	—
Cash from Operating Activities	50.9	139.0	26.7	82.1	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	144.3	60.6	42.4	57.6	—
+ Disp of Fixed Assets	0.9	0.6	0.0	0.0	—
+ Purchase of Investments (Equity / Debt)	0.7	0.0	0.0	32.8	—
+ Investment in Partnership Firms / LLPs	0.0	0.0	30.5	0.0	—
+ Loans & Advances Made	10.1	0.0	0.0	0.0	—
+ Dividends Received — Investing	0.0	0.0	0.8	0.0	—
+ Interest Received — Investing	0.7	1.2	0.9	3.0	—
+ Other Inflows / (Outflows) — Investing	28.8	-7.7	-4.1	34.5	—
Cash from Investing Activities	-124.6	-66.5	-75.3	-53.0	—
Cash from Financing Activities
+ Proceeds from Issue of Shares	0.0	0.0	222.9	0.0	—
+ Proceeds from Exercise of Stock Options	0.5	0.6	0.2	0.5	—
+ Proceeds from Borrowings	80.8	25.2	0.0	68.9	—
+ Repayment of Borrowings	-52.3	0.0	70.6	17.2	—
+ Payment of Lease Liabilities	8.2	10.9	10.5	16.4	—
+ Interest Paid	51.9	72.8	69.6	60.6	—
+ Other Inflows / (Outflows) — Financing	-13.9	-28.1	0.0	0.0	—
Cash from Financing Activities	59.7	-86.0	72.4	-24.6	—
Net Changes in Cash (pre-FX)	-14.1	-13.5	23.8	4.5	—
Net Changes in Cash	-14.1	-13.5	23.8	4.5	—
Closing Cash	93.7	80.3	—	—	—
Reference Items
EBITDA	205.3	73.9	208.1	106.9	85.9
EBITDA Margin %	12.21	4.58	12.49	6.20	4.61
Free Cash Flow (CFO − Capex)	-93.4	78.4	-15.7	24.5	24.5
Free Cash Flow to Equity	—	-116.3	-97.3	-13.6	—
Free Cash Flow per Basic Share	-4.86	4.08	-0.82	1.28	1.28
Price to Free Cash Flow	—	—	—	—	64.54
Cash Flow to Net Income	1.28	-1.33	-0.17	3.49	—
Cash Paid for Taxes	20.2	47.5	38.2	23.7	—
Cash Paid for Interest	51.9	72.8	69.6	60.6	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.